Your browser doesn't support javascript.
loading
Roles of Mesenchymal Stem Cells in Breast Cancer Therapy: Engineered Stem Cells and Exosomal Cell-Free Based Therapy.
Fath, Mohsen Karami; Zadian, Seyed Sajjad; Torbati, Samaneh Mohammad Bagherzadeh; Saqagandomabadi, Vahid; Afshar, Omid Yousefi; Khalilzad, Mohammad; Abedi, Sara; Moliani, Afshin; Barati, Ghasem.
Afiliação
  • Fath MK; Department of Cellular and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.
  • Zadian SS; Department of Immunology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Torbati SMB; Faculty of Medicine, Babol University of Medical Sciences, Mazandaran, Iran.
  • Saqagandomabadi V; Department of Biomedicine, Neuroscience and Advanced Diagnostics, University of Palermo, Palermo, Italy.
  • Afshar OY; Clinical Research Development Unit, Valiasr Hospital, Tabriz, Iran.
  • Khalilzad M; Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Abedi S; Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.
  • Moliani A; Isfahan Medical Students Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Barati G; Stem Cell Technology Research Center, Tehran, Iran.
Curr Mol Med ; 2024 Jan 24.
Article em En | MEDLINE | ID: mdl-38275063
ABSTRACT
Breast cancer has a high prevalence among women, with a high mortality rate. The number of people who suffer from breast cancer disease is increasing, whereas metastatic cancers are mostly incurable, and existing therapies have unfavorable side effects. For an extended duration, scientists have dedicated their efforts to exploring the potential of mesenchymal stem cells (MSCs) for the treatment of metastatic cancers, including breast cancer. MSCs could be genetically engineered to boost their anticancer potency. Furthermore, MSCs can transport oncolytic viruses, suicide genes, and anticancer medicines to tumors. Extracellular vesicles (EVs) are MSC products that have attracted scientist's attention as a cell-free treatment. This study narratively reviews the current state of knowledge on engineered MSCs and their EVs as promising treatments for breast cancer.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Curr Mol Med Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Curr Mol Med Ano de publicação: 2024 Tipo de documento: Article